inTEST (INTT) Competitors

$16.33 -2.21 (-11.92%)

Closing price 04:00 PM Eastern

Extended Trading

$16.43 +0.10 (+0.59%)

As of 06:44 PM Eastern

INTT vs. TRNS, CTKB, FEIM, LAB, and OPTX

Should you be buying inTEST stock or one of its competitors? The main competitors of inTEST include Transcat (TRNS), Cytek Biosciences (CTKB), Frequency Electronics (FEIM), Standard BioTools (LAB), and Syntec Optics (OPTX). These companies are all part of the "measuring and control equipment" industry.

How does inTEST compare to Transcat?

inTEST (NYSE:INTT) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

: Transcat has higher revenue and earnings than inTEST. inTEST is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
inTEST $113.83M 1.79 $9.34M -$0.21 N/A
Transcat $319.69M 2.20 $14.52M $0.85 88.62
: inTEST has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.
: 63.2% of inTEST shares are held by institutional investors. Comparatively, 98.3% of Transcat shares are held by institutional investors. 7.0% of inTEST shares are held by company insiders. Comparatively, 2.8% of Transcat shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Transcat has a net margin of 2.47% compared to inTEST's net margin of 2.33%. Transcat's return on equity of 6.15% beat inTEST's return on equity.
Company Net Margins Return on Equity Return on Assets
inTEST 2.33% 5.31% 3.42%
Transcat 2.47% 6.15% 4.15%
: inTEST presently has a consensus price target of $19.00, indicating a potential upside of 16.35%. Transcat has a consensus price target of $105.33, indicating a potential upside of 39.83%. Given Transcat's higher possible upside, analysts clearly believe Transcat is more favorable than inTEST.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
inTEST
0 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
Transcat
2 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

1 Strong Buy rating(s)
2.40
: In the previous week, inTEST had 2 more articles in the media than Transcat. MarketBeat recorded 4 mentions for inTEST and 2 mentions for Transcat. Transcat's average media sentiment score of 1.30 beat inTEST's score of 0.00 indicating that Transcat is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
inTEST
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Transcat
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$113.83M	1.79	$9.34M	-$0.21	N/A
Transcat	$319.69M	2.20	$14.52M	$0.85	88.62

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
Transcat	2.47%	6.15%	4.15%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Transcat	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Transcat	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Transcat beats inTEST on 13 of the 17 factors compared between the two stocks.

How does inTEST compare to Cytek Biosciences?

inTEST (NYSE:INTT) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

: inTEST has higher earnings, but lower revenue than Cytek Biosciences. inTEST is trading at a lower price-to-earnings ratio than Cytek Biosciences, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
inTEST $113.83M 1.79 $9.34M -$0.21 N/A
Cytek Biosciences $201.49M 3.06 -$66.54M -$0.51 N/A
: inTEST has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500.
: 63.2% of inTEST shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 7.0% of inTEST shares are held by company insiders. Comparatively, 10.3% of Cytek Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: inTEST has a net margin of 2.33% compared to Cytek Biosciences' net margin of -33.02%. inTEST's return on equity of 5.31% beat Cytek Biosciences' return on equity.
Company Net Margins Return on Equity Return on Assets
inTEST 2.33% 5.31% 3.42%
Cytek Biosciences -33.02% -7.70% -5.89%
: inTEST presently has a consensus price target of $19.00, indicating a potential upside of 16.35%. Cytek Biosciences has a consensus price target of $5.38, indicating a potential upside of 12.45%. Given inTEST's stronger consensus rating and higher possible upside, equities analysts clearly believe inTEST is more favorable than Cytek Biosciences.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
inTEST
0 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
Cytek Biosciences
2 Sell rating(s)

2 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, inTEST had 3 more articles in the media than Cytek Biosciences. MarketBeat recorded 4 mentions for inTEST and 1 mentions for Cytek Biosciences. inTEST's average media sentiment score of 0.00 equaled Cytek Biosciences'average media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
inTEST
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cytek Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$113.83M	1.79	$9.34M	-$0.21	N/A
Cytek Biosciences	$201.49M	3.06	-$66.54M	-$0.51	N/A

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
Cytek Biosciences	-33.02%	-7.70%	-5.89%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cytek Biosciences	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cytek Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

inTEST beats Cytek Biosciences on 10 of the 15 factors compared between the two stocks.

How does inTEST compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and inTEST (NYSE:INTT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

: In the previous week, Frequency Electronics had 2 more articles in the media than inTEST. MarketBeat recorded 6 mentions for Frequency Electronics and 4 mentions for inTEST. Frequency Electronics' average media sentiment score of 0.66 beat inTEST's score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Frequency Electronics
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
inTEST
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Frequency Electronics currently has a consensus target price of $43.67, indicating a potential downside of 22.33%. inTEST has a consensus target price of $19.00, indicating a potential upside of 16.35%. Given inTEST's higher possible upside, analysts plainly believe inTEST is more favorable than Frequency Electronics.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
inTEST
0 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
: Frequency Electronics has higher earnings, but lower revenue than inTEST. inTEST is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Frequency Electronics $67.82M 8.16 $23.69M $0.75 74.96
inTEST $113.83M 1.79 $9.34M -$0.21 N/A
: Frequency Electronics has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, inTEST has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500.
: 58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by insiders. Comparatively, 7.0% of inTEST shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: Frequency Electronics has a net margin of 10.78% compared to inTEST's net margin of 2.33%. Frequency Electronics' return on equity of 12.69% beat inTEST's return on equity.
Company Net Margins Return on Equity Return on Assets
Frequency Electronics 10.78% 12.69% 7.84%
inTEST 2.33% 5.31% 3.42%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Frequency Electronics	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$67.82M	8.16	$23.69M	$0.75	74.96
inTEST	$113.83M	1.79	$9.34M	-$0.21	N/A

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
inTEST	2.33%	5.31%	3.42%

Summary

Frequency Electronics beats inTEST on 10 of the 14 factors compared between the two stocks.

How does inTEST compare to Standard BioTools?

inTEST (NYSE:INTT) and Standard BioTools (NASDAQ:LAB) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

: inTEST presently has a consensus target price of $19.00, suggesting a potential upside of 16.35%. Standard BioTools has a consensus target price of $1.35, suggesting a potential upside of 37.90%. Given Standard BioTools' higher probable upside, analysts plainly believe Standard BioTools is more favorable than inTEST.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
inTEST
0 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
Standard BioTools
1 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.67
: inTEST has higher revenue and earnings than Standard BioTools. inTEST is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
inTEST $113.83M 1.79 $9.34M -$0.21 N/A
Standard BioTools $85.33M 4.48 -$74.90M -$0.20 N/A
: inTEST has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.
: 63.2% of inTEST shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 7.0% of inTEST shares are held by company insiders. Comparatively, 23.2% of Standard BioTools shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
: inTEST has a net margin of 2.33% compared to Standard BioTools' net margin of -59.39%. inTEST's return on equity of 5.31% beat Standard BioTools' return on equity.
Company Net Margins Return on Equity Return on Assets
inTEST 2.33% 5.31% 3.42%
Standard BioTools -59.39% -11.21% -8.51%
: In the previous week, inTEST and inTEST both had 4 articles in the media. Standard BioTools' average media sentiment score of 0.93 beat inTEST's score of 0.00 indicating that Standard BioTools is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
inTEST
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Standard BioTools
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$113.83M	1.79	$9.34M	-$0.21	N/A
Standard BioTools	$85.33M	4.48	-$74.90M	-$0.20	N/A

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
Standard BioTools	-59.39%	-11.21%	-8.51%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Standard BioTools	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

inTEST beats Standard BioTools on 10 of the 15 factors compared between the two stocks.

How does inTEST compare to Syntec Optics?

inTEST (NYSE:INTT) and Syntec Optics (NASDAQ:OPTX) are both small-cap measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

: inTEST presently has a consensus target price of $19.00, suggesting a potential upside of 16.35%. Given inTEST's stronger consensus rating and higher probable upside, equities analysts plainly believe inTEST is more favorable than Syntec Optics.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
inTEST
0 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.50
Syntec Optics
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: inTEST has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
inTEST $113.83M 1.79 $9.34M -$0.21 N/A
Syntec Optics $28.08M 10.12 -$1.79M -$0.05 N/A
: inTEST has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, Syntec Optics has a beta of -0.93, suggesting that its share price is 193% less volatile than the S&P 500.
: 63.2% of inTEST shares are held by institutional investors. 7.0% of inTEST shares are held by company insiders. Comparatively, 0.8% of Syntec Optics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
: inTEST has a net margin of 2.33% compared to Syntec Optics' net margin of -6.38%. inTEST's return on equity of 5.31% beat Syntec Optics' return on equity.
Company Net Margins Return on Equity Return on Assets
inTEST 2.33% 5.31% 3.42%
Syntec Optics -6.38% -17.19% -7.14%
: In the previous week, Syntec Optics had 3 more articles in the media than inTEST. MarketBeat recorded 7 mentions for Syntec Optics and 4 mentions for inTEST. Syntec Optics' average media sentiment score of 0.66 beat inTEST's score of 0.00 indicating that Syntec Optics is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
inTEST
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Syntec Optics
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$113.83M	1.79	$9.34M	-$0.21	N/A
Syntec Optics	$28.08M	10.12	-$1.79M	-$0.05	N/A

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
Syntec Optics	-6.38%	-17.19%	-7.14%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syntec Optics	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

inTEST beats Syntec Optics on 12 of the 16 factors compared between the two stocks.

Get inTEST News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INTT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INTT vs. The Competition

Export

Metric	inTEST	Instruments to measure electricity Industry	Computer Sector	NYSE Exchange
Market Cap	$204.06M	$204.06M	$37.15B	$22.95B
Dividend Yield	N/A	N/A	3.16%	4.03%
P/E Ratio	71.00	71.00	77.83	28.58
Price / Sales	1.79	1.79	617.96	23.58
Price / Cash	5.75	5.75	46.31	19.03
Price / Book	2.06	2.06	9.17	4.68
Net Income	$9.34M	$9.34M	$1.03B	$1.07B
7 Day Performance	-3.37%	-3.37%	4.88%	0.89%
1 Month Performance	16.06%	16.06%	14.33%	6.56%
1 Year Performance	186.49%	186.49%	168.77%	31.66%

inTEST Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INTT inTEST	1.2684 of 5 stars	$16.33 -11.9%	$19.00 +16.4%	N/A	$204.06M	$113.83M	71.00	320	News Coverage Gap Down High Trading Volume
TRNS Transcat	2.2677 of 5 stars	$75.68 -2.1%	$105.33 +39.2%	N/A	$721.29M	$319.69M	89.04	1,245	Positive News
CTKB Cytek Biosciences	0.7505 of 5 stars	$4.57 +2.5%	$5.38 +17.6%	N/A	$570.28M	$201.49M	N/A	500	Positive News Upcoming Earnings
FEIM Frequency Electronics	0.923 of 5 stars	$48.77 -2.6%	$43.67 -10.5%	N/A	$492.73M	$67.82M	65.03	200	News Coverage Gap Up
LAB Standard BioTools	2.8675 of 5 stars	$0.92 +2.7%	$1.35 +46.4%	N/A	$350.48M	$85.33M	N/A	620	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:INTT) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

inTEST (INTT) Competitors

INTT vs. TRNS, CTKB, FEIM, LAB, and OPTX

How does inTEST compare to Transcat?

Summary

How does inTEST compare to Cytek Biosciences?

Summary

How does inTEST compare to Frequency Electronics?

Summary

How does inTEST compare to Standard BioTools?

Summary

How does inTEST compare to Syntec Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INTT vs. The Competition

inTEST Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

inTEST (INTT) Competitors

INTT vs. TRNS, CTKB, FEIM, LAB, and OPTX

How does inTEST compare to Transcat?

Summary

How does inTEST compare to Cytek Biosciences?

Summary

How does inTEST compare to Frequency Electronics?

Summary

How does inTEST compare to Standard BioTools?

Summary

How does inTEST compare to Syntec Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INTT vs. The Competition

inTEST Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools